Navigation Links
OHSU scientists partner with others to form center aimed at combating infectious diseases
Date:4/15/2009

PORTLAND, Ore. Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.

Based at OHSU, the collaborative Pacific Northwest Regional Center for Excellence (PNWRCE) for Biodefense and Emerging Infectious Diseases was established through a five-year, $40.7 million cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health. Jay Nelson, Ph.D., is director of the PNWRCE and OHSU's Vaccine and Gene Therapy Institute (VGTI), and Michael Katze, Ph.D., UW professor of microbiology, is co-director of the PNWRCE.

"Since the anthrax attacks in 2001, the country has rapidly expanded our ability to detect and combat infectious diseases whether they are spread naturally or through a bioterrorist attack," said Dr. Nelson. "These regional research centers located across the country serve to better protect the population while at the same time conducting research aimed at preventing or successfully combating a public health crisis recent examples would include threats posed in the past few years by influenza, West Nile virus and SARS."

Members of the PNWRCE will work closely with public health departments in all participating Northwest states in training and research. The members will also collaborate with newly funded science initiatives within the state such as the Oregon Translational Research and Drug Development Institute. OTRADI provides crucial research services to Oregon researchers involved in pharmaceutical development and will be an important partner in the research.

PNWRCE researchers will study a broad range of diseases and viruses, including Ebola, Dengue, SARS, avian and 1918 influenza, dengue f
'/>"/>

Contact: Jim Newman
newmanj@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. BIDMC scientists receive creativity awards from Prostate Cancer Foundation
2. Scientists discover way to jumpstart bones healing process
3. Scripps research scientists model 3D structures of proteins that control human clock
4. Scientists Identify Key Gene That Protects Against Leukemia
5. Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
6. Scientists Now Warn That White Wine Can Lead To Teeth Staining
7. Scientists Uncover New Weapon Against Huntingtons
8. Scientists show how a neuron gets its shape
9. Neuroscientists demonstrate link between brainwave acticity and visual perception
10. Einstein scientists propose new theory of autism
11. International Scientists Secure Quality in Molecular Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... -- The University HealthSystem Consortium (UHC) recognized 10 ... in UHC,s Supply Chain Optimization Program. The leaders ... best practices in supply chain program participation. ... winners were determined using 2008 data and based ... and use of UHC resources. ,, Characteristics of ...
(Date:12/6/2009)... in Cambridge have discovered that the loss of a key ... is the first study to show that this kind of ... in Nature . , The study, led by Dr ... Hurles from the Wellcome Trust Sanger Institute, looked at 300 ... entire genome looking for types of mutation known as copy ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Onyx Pharmaceuticals, Inc. ... data from the pivotal Phase 2b 003-A1 study, ... is well-tolerated in heavily pre-treated relapsed and refractory ... at the ASH/ASCO Joint Symposium at the 51st ... (ASH) in New Orleans. Enrollment in this trial ...
(Date:12/6/2009)... Sleep Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... problems with herbal or natural sleep aids from ... remedies for a good cause. The submissions will ... Sleep Aids ,Encyclopedia, by YOU, to be sold ... site will donate 100% of the proceeds ,from ...
(Date:12/5/2009)... been significant scientific advances in the field of blood ... understanding of how certain diseases progress in order to ... best care. Research presented today at the 51st Annual ... induction therapies for managing multiple myeloma, the importance of ...
Breaking Medicine News(10 mins):Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
... June 2008: Infections during the first year of ... specific types of arthritis later in life, according to ... the Annual Congress of the European League Against Rheumatism ... Sweden found that infants who were hospitalised for infection ...
... New data presented today at EULAR 2008, the ... Paris, France, show that over half of rheumatoid arthritis ... or infliximab were added to their methotrexate treatment regimen, ... , The ATTEST (Abatacept or infliximab versus placebo, a ...
... BMJ debate the issue of selling kidneys. , ... the solution to the growing shortage of kidneys for transplantation, ... Minnesota. , In many areas of the United States ... is five years, but in some parts it is as ...
... candid about, recent publicized lead testing results; sites difficulty in confirming two ... ... Attorney Christopher Grell,ordered lab tests on behalf of his client on three ... the,Fraud Discovery Institute., On May 19th the Fraud Discovery Institute released ...
... Ascension Orthopedics, Inc., a,leader in orthopedic extremity implants, ... Warrender, Jr., John F. Walters and David,C. Furr, ... and,experience will make a substantial contribution to the ... on April 14 as Senior Vice President of,Global ...
... today that it has initiated a Phase 1 ... for the detection and staging of metastatic prostate ... small molecule radiopharmaceutical candidates that target prostate-specific membrane ... select a lead candidate for further development and ...
Other Medicine News:Health News:Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis 2Health News:Abatacept and infliximab improve clinical response over time in methotrexate-refractory RA patients 2Health News:What's wrong with selling kidneys? 2Health News:Plaintiff's Lawyer Orders Lead Testing on 3 Popular Herbalife Products; Results Show 728% More Lead Than Allowed by Law Under Proposition 65 Violation 2Health News:Three Industry Veterans Join Ascension Orthopedics 2Health News:Three Industry Veterans Join Ascension Orthopedics 3Health News:Molecular insight begins Trofex Phase 1 trial for detection of metastatic prostate cancer 2
(Date:12/4/2009)... Depression, anxiety disorder, bipolar disorder, Attention Deficit ... are among the comorbidities reported to occur more ... diagnosed with epilepsy versus those without an epilepsy ... households across the U.S. ,, Findings from " ...
(Date:12/3/2009)... 3 Allen Medical Systems, a subsidiary of Hill-Rom ... the launch of its new Allen Amatech(TM) OEM (Original ... ,, The website reinforces the Allen Amatech(TM) brand ... product catalog, with detailed descriptions and design specifications for ...
(Date:12/3/2009)... 3 A genetic variation that may indicate a ... if exposed to certain pharmaceutical therapies or chemicals is ... leader Quest Diagnostics (NYSE: DGX ) will ... Annual Meeting and Exposition, December 5-8, 2009, in New ...
Breaking Medicine Technology:Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Medical Malpractice Victim Helps Uphold Constitutional Rights of Patients in Washington State Supreme Court Decision Perey Law Announces 57593 1Medical Malpractice Victim Helps Uphold Constitutional Rights of Patients in Washington State Supreme Court Decision Perey Law Announces 57593 2Medical Malpractice Victim Helps Uphold Constitutional Rights of Patients in Washington State Supreme Court Decision Perey Law Announces 57593 3HealthFitness to Present at the Canaccord Adams Healthy Living Conference 57590 1HealthFitness to Present at the Canaccord Adams Healthy Living Conference 57590 2Time to Turn the Town Pink 57587 1Time to Turn the Town Pink 57587 2
... ALUS ), the worldwide leader in intravascular ... featuring both patient cases and laboratory research in ... this week at the American,Society of Anesthesiologists (ASA) ... Arie Blitz, Director of Heart Transplantation and Assist ...
... TR-701 Phase 1 Clinical Trial Results Disclosed, ... Therapeutics, Inc., a,biopharmaceutical company developing "Best-in-Class" drugs ... today that the results,of multiple studies on ... pipeline,programs will be presented in eighteen presentations ...
Other Medicine Technology:Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 2Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 3Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 2Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 3
... quick and easy automated refill system ... space on your laboratory bench and ... easy-to-use, one-hand system, you only need ... of Diamond Tips. All sizes of ...
10 L, Stacked Rack, 96 tips/rack 5 racks/stack, clear Recommended for 2, 5, 10 L pipettes....
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
... HerpeSelect® 2 ELISA IgG test is intended ... human IgG class antibodies to HSV-2 in ... 1 ELISA IgG, the test is indicated ... for aiding in the presumptive,diagnosis of HSV ...
Medicine Products: